Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, BioCryst Pharmaceuticals (BCRX) has a market cap of $1.55 billion USD. According to our data, BioCryst Pharmaceuticals is ranked No.4380 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $1.55 B |
-0.73%
|
| Dec 31, 2024 | $1.56 B |
25.54%
|
| Dec 29, 2023 | $1.24 B |
-47.82%
|
| Dec 30, 2022 | $2.38 B |
-17.11%
|
| Dec 31, 2021 | $2.87 B |
85.91%
|
| Dec 31, 2020 | $1.54 B |
115.94%
|
| Dec 31, 2019 | $0.71 B |
-57.25%
|
| Dec 31, 2018 | $1.67 B |
64.36%
|
| Dec 29, 2017 | $1.02 B |
-22.43%
|
| Dec 30, 2016 | $1.31 B |
-38.66%
|
| Dec 31, 2015 | $2.14 B |
-15.13%
|
| Dec 31, 2014 | $2.52 B |
60.00%
|
| Dec 31, 2013 | $1.57 B |
435.21%
|
| Dec 31, 2012 | $0.29 B |
-42.51%
|
| Dec 30, 2011 | $0.51 B |
-52.22%
|
| Dec 31, 2010 | $1.07 B |
-19.97%
|
| Dec 31, 2009 | $1.34 B |
371.53%
|
| Dec 31, 2008 | $0.28 B |
-77.83%
|
| Dec 31, 2007 | $1.28 B |
-46.54%
|
| Dec 29, 2006 | $2.39 B |
-30.99%
|
| Dec 30, 2005 | $3.47 B |
189.79%
|
| Dec 31, 2004 | $1.20 B |
-15.62%
|
| Dec 31, 2003 | $1.42 B |
613.54%
|
| Dec 31, 2002 | $0.20 B |
-75.76%
|
| Dec 31, 2001 | $0.82 B |
-40.23%
|
| Dec 29, 2000 | $1.37 B |
-77.54%
|
| Dec 31, 1999 | $6.11 B |
321.43%
|
| Dec 31, 1998 | $1.45 B |
0.00%
|
| Dec 31, 1997 | $1.45 B |
-57.25%
|
| Dec 31, 1996 | $3.39 B |
77.03%
|
| Dec 29, 1995 | $1.92 B |
100.00%
|
| Dec 30, 1994 | $0.96 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
USA
|
 Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
USA
|
 Ionis Pharmaceuticals
IONS
|
$4.51 B |
0.000 M
|
USA
|
 Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
USA
|
 Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
USA
|
 CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
USA
|
| Market Cap | = | BCRX Stock Price | * | BCRX Shares Outstanding |
| = | $7.40 | * | 0.21 B | |
| = | $1.55 B |